Repare Therapeutics Inc.(NASDAQ:RPTX) 
Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic lethality approach in Canada and the United States. It uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform, to discover, validat...
Website: https://www.reparerx.com
Founded: 2016
Full Time Employees: 180
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.01
H 1.06
L 0.98
C 1.00
V 281,356
10EMA 1.00
20EMA 1.00
60EMA 1.00
120EMA 1.00
250EMA 1.00